Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1681/ASN.2014020205 http://scihub22266oqcxt.onion/10.1681/ASN.2014020205 C4341479!4341479!25150154     free     free     free       J+Am+Soc+Nephrol 2015 ; 26 (3): 515-23 Nephropedia Template TP {{tp|p=25150154|t=2015. Current Status of Bicarbonate in CKD |pdf=|usr=}}{{25150154}} gab.com Text Current Status of Bicarbonate in CKD JO: J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=25150154 #FOAvip Metabolic acidosis was one of the earliest complications to be recognized and explained pathologically in patients with CKD. Despite the accumulated evidence of deleterious effects of acidosis, treatment of acidosis has been tested very little, especially with respect to standard clinical outcomes. On the basis of fundamental research and small alkali supplementation trials, correcting metabolic acidosis has a strikingly broad array of potential benefits. This review summarizes the published evidence on the association between serum bicarbonate and clinical outcomes. We discuss the role of alkali supplementation in CKD as it relates to retarding kidney disease progression, improving metabolic and musculoskeletal complications. Twit Text FOAVip Current Status of Bicarbonate in CKD ????J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=25150154 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25150154 #FOAvip English Wikipedia <ref>{{Cite pmid|25150154}}</ref> Current Status of Bicarbonate in CKD #MMPMID25150154 Dobre M; Rahman M; Hostetter TH J Am Soc Nephrol 2015[Mar]; 26 (3): 515-23 PMID25150154show ga Metabolic acidosis was one of the earliest complications to be recognized and explained pathologically in patients with CKD. Despite the accumulated evidence of deleterious effects of acidosis, treatment of acidosis has been tested very little, especially with respect to standard clinical outcomes. On the basis of fundamental research and small alkali supplementation trials, correcting metabolic acidosis has a strikingly broad array of potential benefits. This review summarizes the published evidence on the association between serum bicarbonate and clinical outcomes. We discuss the role of alkali supplementation in CKD as it relates to retarding kidney disease progression, improving metabolic and musculoskeletal complications. äCurrent Status of Bicarbonate in CKD (epmc).pdf DeepDyve Pubget Overpricing